Canton Strategic Holdings, Inc. (CNTN)
NASDAQ: CNTN · Real-Time Price · USD
2.490
-0.200 (-7.43%)
Sep 29, 2026, 10:39 AM EDT - Market open
Canton Strategic Holdings Market Cap
Canton Strategic Holdings has a market cap or net worth of $198.41 million as of September 29, 2026. Its market cap has increased by 1,012.92% in one year.
Market Cap
198.41M
Enterprise Value
161.17M
1-Year Change
1,012.92%
Ranking
Category
Stock Price
$2.49
ChartMarket Cap Chart
Since January 12, 2022, Canton Strategic Holdings's market cap has increased from $32.56M to $198.41M, an increase of 509.31%. That is a compound annual growth rate of 46.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2026 | 198.41M | 79.67% |
| Dec 31, 2025 | 110.43M | 2,713.07% |
| Dec 31, 2024 | 3.93M | 205.38% |
| Dec 29, 2023 | 1.29M | -71.40% |
| Dec 30, 2022 | 4.49M | -86.20% |
| Jan 12, 2022 | 32.56M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Keros Therapeutics | 223.65M |
| Yarrow Bioscience | 223.30M |
| Compugen | 220.71M |
| Cartesian Therapeutics | 218.14M |
| Anavex Life Sciences | 217.84M |
| Protalix BioTherapeutics | 216.74M |
| Adagene | 214.86M |
| Eledon Pharmaceuticals | 214.74M |